MRCHF (H U Group Holdings) ROC (Joel Greenblatt) %: 5.07% (As of Mar. 2026) — 40% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MRCHF H U Group Holdings Inc MRCHF
63 GF Score
Price $20.90
GF Value $19.09
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is H U Group Holdings ROC (Joel Greenblatt) %?

H U Group Holdings MRCHF -0.18% 63 ROC (Joel Greenblatt) % is 5.07% as of Mar. 2026, which is 40% below its 10-year median of 8.45. GuruFocus rates MRCHF with a GF Score™ of 63/100 and a GF Value™ of $19.09 (Fairly Valued). The stock has 5 warning signs investors should review. Among 211 Medical Diagnostics & Research companies, H U Group Holdings ranks better than 61.61% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. H U Group Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 5.07%.

The historical rank and industry rank for H U Group Holdings's ROC (Joel Greenblatt) % or its related term are showing as below:

MRCHF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -10.84   Med: 8.45   Max: 45.45
Current: 9.07

During the past 13 years, H U Group Holdings's highest ROC (Joel Greenblatt) % was 45.45%. The lowest was -10.84%. And the median was 8.45%.

MRCHF's ROC (Joel Greenblatt) % is ranked better than
61.61% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.02 vs MRCHF: 9.07

H U Group Holdings's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


H U Group Holdings  (OTCPK:MRCHF) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


H U Group Holdings ROC (Joel Greenblatt) % Related Terms


H U Group Holdings ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for H U Group Holdings's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

H U Group Holdings ROC (Joel Greenblatt) % Chart

H U Group Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.63 20.88 -6.05 3.45 8.73

H U Group Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.20 -3.05 3.63 30.08 5.07

MRCHF vs TMO, DHR, IDXX: ROC (Joel Greenblatt) % Comparison

For the Diagnostics & Research subindustry, H U Group Holdings's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


H U Group Holdings ROC (Joel Greenblatt) % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, H U Group Holdings's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where H U Group Holdings's ROC (Joel Greenblatt) % falls into.


MRCHF
63GF Score
H U Group Holdings Inc MRCHF
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

H U Group Holdings ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(312.407 + 154.86 + 46.128) - (197.075 + 0 + 97.765)
=218.555

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(296.327 + 151.541 + 45.69) - (195.157 + 0 + 88.591)
=209.81

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of H U Group Holdings for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=32.04/( ( (424.193 + max(218.555, 0)) + (412.118 + max(209.81, 0)) )/ 2 )
=32.04/( ( 642.748 + 621.928 )/ 2 )
=32.04/632.338
=5.07 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 5.07% mean?
H U Group Holdings (MRCHF) has a ROC (Joel Greenblatt) % of 5.07% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on H U Group Holdings and its competitors. This is 40% below median its historical median of 8.45. According to the industry distribution chart, H U Group Holdings ranks #81 out of 211 companies in the Medical Diagnostics & Research industry, placing it in the top 38.4%.
Is H U Group Holdings' ROC (Joel Greenblatt) % too high?
H U Group Holdings' current ROC (Joel Greenblatt) % of 5.07% is 40% below median its 10-year median of 8.45. Based on the distribution chart, H U Group Holdings ranks #81 out of 211 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, H U Group Holdings has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does H U Group Holdings' ROC (Joel Greenblatt) % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, H U Group Holdings ranks #81 out of 211 companies for ROC (Joel Greenblatt) %. This puts H U Group Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Diagnostics & Research company?
A good ROC (Joel Greenblatt) % depends on the Medical Diagnostics & Research industry context. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on H U Group Holdings and its competitors. H U Group Holdings's current ROC (Joel Greenblatt) % is 5.07%, which is 40% below median its own 10-year median of 8.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H U Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, H U Group Holdings (MRCHF) is currently considered Fairly Valued. The stock's GF Value™ is $19.09, compared to a current price of $20.90 — trading 9.5% above its estimated fair value. The current ROC (Joel Greenblatt) % is 5.07%, which is 40% below median its 10-year median of 8.45. H U Group Holdings' overall GF Score™ is 63/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For H U Group Holdings (MRCHF), the current ROC (Joel Greenblatt) % is 5.07% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is H U Group Holdings (MRCHF) Overvalued in 2026?

Based on GuruFocus' analysis, H U Group Holdings stock appears to be overvalued. The current stock price of $20.90 is trading 9.5% above its estimated GF Value™ of $19.09. GuruFocus considers H U Group Holdings to be Fairly Valued.

Key valuation signals for MRCHF:

  • ROC (Joel Greenblatt) %: 5.07% (40% below median its 10-year median of 8.45)
  • GF Value™: $19.09 vs. price of $20.90 (9.5% above fair value)
  • GF Score™: 63/100 with 5 warning signs

No single metric tells the full story. See the MRCHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


H U Group Holdings Business Description

Other Exchanges 4544:Japan
Address Shinjuku Mitsui Building, 2-1-1 Nishishinjuku, Shinjuku-ku, Tokyo, JPN, 163-0408
H U Group Holdings Inc operates in the healthcare field, focusing on clinical laboratory testing and reagents. The company is engaged in four main businesses. The Clinical Laboratory Testing Business receives samples taken from patients at medical institutions to test for the disease and confirm the condition of the patient's health; In Vitro Diagnostics develops, manufactures, and sells testing reagents and equipment inside and outside Japan; Sterilization & Related Services Business provides a range of medical-related services including sterilization; and Emerging New Business & Others is a new business for future growth.
63GF Score

Get the complete analysis for MRCHF

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$20.90
Price
$19.09
GF Value